6 min read
Cheap beta-blockers could fight deadly triple-negative breast cancer
news
health
A new laboratory study suggests cheap beta-blocker drugs can slow the spread of triple-negative breast cancer.
The finding could change treatment strategies for a hard-to-treat cancer subtype worldwide. ( Monash University press release )
Triple-negative breast cancer, or TNBC, lacks three common receptors.
Doctors find TNBC hard to treat with hormone or HER2-targeted therapies. ( World Journal review on TNBC prevalence and challenges )
The Monash University team studied how beta-2 adrenoceptor signals drive TNBC invasion.
They found a regulatory gene called HOXC12 helps couple the receptor to pro-invasion signals. ( Monash University press release )
#breastcancer
#TNBC
#betaBlockers
+5 more